| Nordimet 7.5 mg solution for injection in pre-filled pen EU/1/16/1124/001 |
Methotrexate |
Nordic Group B.V. |
— |
| Norvir 100 mg film-coated tablets EU/1/96/016/005-006 |
Ritonavir |
AbbVie Deutschland GmbH & Co. KG |
— |
| Norvir 100 mg powder for oral suspension EU/1/96/016/009 |
Ritonavir |
AbbVie Deutschland GmbH & Co. KG |
— |
| NovoEight 1000 IU powder and solvent for solution for injection EU/1/13/888/003 |
Turoctocog alfa |
Novo Nordisk A/S |
— |
| NovoEight 1500 IU powder and solvent for solution for injection EU/1/13/888/004 |
Turoctocog alfa |
Novo Nordisk A/S |
— |
| NovoEight 2000 IU powder and solvent for solution for injection EU/1/13/888/005 |
Turoctocog alfa |
Novo Nordisk A/S |
— |
| NovoEight 250 IU powder and solvent for solution for injection EU/1/13/888/001 |
Turoctocog alfa |
Novo Nordisk A/S |
— |
| NovoEight 3000 IU powder and solvent for solution for injection EU/1/13/888/006 |
Turoctocog alfa |
Novo Nordisk A/S |
— |
| NovoEight 500 IU powder and solvent for solution for injection EU/1/13/888/002 |
Turoctocog alfa |
Novo Nordisk A/S |
— |
| NovoMix 30 FlexPen 100 units/ml suspension for injection in pre-filled pen EU/1/00/142/09-010 |
Insulin aspart |
Novo Nordisk A/S |
— |
| NovoMix 30 Penfill 100 units/ml suspension for injection in cartridge EU/1/00/142/004-05 |
Insulin aspart |
Novo Nordisk A/S |
— |
| NovoMix 50 FlexPen 100 units/ml suspension for injection in pre-filled pen EU/1/00/142/14-16 |
Insulin aspart |
Novo Nordisk A/S |
— |
| NovoMix 50 Penfill 100 units/ml suspension for injection in cartridge EU/1/00/142/11-13 |
Insulin aspart |
Novo Nordisk A/S |
— |
| NovoNorm 0.5 mg tablets EU/1/98/076/004 |
Repaglinide |
Novo Nordisk A/S |
— |
| NovoNorm 0.5 mg tablets EU/1/98/076/005 |
Repaglinide |
Novo Nordisk A/S |
— |
| NovoNorm 0.5 mg tablets EU/1/98/076/006 |
Repaglinide |
Novo Nordisk A/S |
— |
| NovoNorm 0.5 mg tablets EU/1/98/076/007 |
Repaglinide |
Novo Nordisk A/S |
— |
| NovoNorm 1 mg tablets EU/1/98/076/011 |
Repaglinide |
Novo Nordisk A/S |
— |
| NovoNorm 1 mg tablets EU/1/98/076/012 |
Repaglinide |
Novo Nordisk A/S |
— |
| NovoNorm 1 mg tablets EU/1/98/076/013 |
Repaglinide |
Novo Nordisk A/S |
— |
| NovoNorm 1 mg tablets EU/1/98/076/014 |
Repaglinide |
Novo Nordisk A/S |
— |
| NovoNorm 2 mg tablets EU/1/98/076/018 |
Repaglinide |
Novo Nordisk A/S |
— |
| NovoNorm 2 mg tablets EU/1/98/076/019 |
Repaglinide |
Novo Nordisk A/S |
— |
| NovoNorm 2 mg tablets EU/1/98/076/020 |
Repaglinide |
Novo Nordisk A/S |
— |
| NovoNorm 2 mg tablets EU/1/98/076/021 |
Repaglinide |
Novo Nordisk A/S |
— |
| NovoRapid 100 U/ml Solution for injection EU/1/99/119/001 |
Insulin aspart |
Novo Nordisk A/S |
— |
| NovoRapid FlexPen 100 U/ml Solution for injection EU/1/99/119/009-011 |
Insulin aspart |
Novo Nordisk A/S |
— |
| NovoRapid FlexTouch 100 U/ml Solution for injection EU/1/99/119/019 |
Insulin aspart |
Novo Nordisk A/S |
— |
| NovoRapid InnoLet 100 U/ml Solution for injection EU/1/99/119/012-014 |
Insulin aspart |
Novo Nordisk A/S |
— |
| NovoRapid Penfill 100 U/ml Solution for injection EU/1/99/119/003 |
Insulin aspart |
Novo Nordisk A/S |
— |
| NovoRapid PumpCart 100 U/ml Solution for injection EU/1/99/119/024-025 |
Insulin aspart |
Novo Nordisk A/S |
— |
| NovoSeven (400 KIU) EU/1/96/006/007 |
Eptacog alfa (activated) |
Novo Nordisk A/S |
— |
| NovoSeven (100 KIU) EU/1/96/006/005 |
Eptacog alfa (activated) |
Novo Nordisk A/S |
— |
| NovoSeven (100 KIU) EU/1/96/006/009 |
Eptacog alfa (activated) |
Novo Nordisk A/S |
— |
| NovoSeven (250 KIU) EU/1/96/006/006 |
Eptacog alfa (activated) |
Novo Nordisk A/S |
— |
| NovoSeven (250 KIU) EU/1/96/006/010 |
Eptacog alfa (activated) |
Novo Nordisk A/S |
— |
| Novoseven (400 KIU) EU/1/96/006/011 |
Eptacog alfa (activated) |
Novo Nordisk A/S |
— |
| NovoSeven (50 KIU) EU/1/96/006/004 |
Eptacog alfa (activated) |
Novo Nordisk A/S |
— |
| NovoSeven (50 KIU) EU/1/96/006/008 |
Eptacog alfa (activated) |
Novo Nordisk A/S |
— |
| NovoThirteen 2500 IU powder and solvent for solution for injection EU/1/12/775/001 |
Rfxiii drug substance |
Novo Nordisk A/S |
— |
| Noxafil 100 mg gastro-resistant tablets EU/1/05/320/002-003 |
Posaconazole |
Merck Sharp & Dohme BV, |
— |
| Noxafil 300 mg concentrate for solution for infusion EU/1/05/320/004 |
Posaconazole |
Merck Sharp & Dohme BV, |
— |
| Noxafil 300 mg gastro-resistant powder for oral suspension EU/1/05/320/005 |
Posaconazole |
Merck Sharp & Dohme BV, |
— |
| Noxafil 40 mg/ml oral suspension EU/1/05/320/001 |
Posaconazole |
Merck Sharp & Dohme BV, |
— |
| Nozinan 25 mg/ml solution for injection/infusion PA23229/008/001 |
LEVOMEPROMAZINE HYDROCHLORIDE |
Neuraxpharm Ireland Limited |
Marketed |
| Nplate 250 micrograms EU/1/08/497/1,3 |
Romiplostim |
Amgen Europe B.V., |
— |
| Nplate 250 micrograms /500 micrograms EU/1/08/497/5-8 |
Romiplostim |
Amgen Europe B.V., |
— |
| Nplate 500 micrograms EU/1/08/497/2,4 |
Romiplostim |
Amgen Europe B.V., |
— |
| NUBEQA 300 mg film-coated tablets EU/1/20/1432/001 |
Darolutamide |
Bayer AG |
— |
| Nucala 100 mg powder for solution for injection EU/1/15/1043/001-002 |
Mepolizumab |
GlaxoSmithKline Trading Services Limited |
— |